Shire PLC

Pharmaceuticals
Ireland
Executive 1Mr. Jeff Poulton, Chief Financial Officer; | Chief Financial Officer;
Executive 2Ms. Tatjana May, General Counsel; Secretary | Vice-Chairman; Chief Executive Officer
Earnings Per Share Growth (%)390.21%
Cost of Goods Sold (US$ Millions)$979
Current Liabilities (US$ Millions)$3,022
Total Assets (US$ Millions)$5,183
Long Term Debt (Millions)N/A
Return on Equity63.46%
Revenue (US$ Millions)$6,022
Total Company Assets$13,632
Revenue Growth (%)22.05%
Net Income (US$ Millions)$3,406
Earnings Per Share (US$)$5.76
Total Equity (US$ Millions)$8,663
Profit Margin (%)56.55%
Debt To Equity Ratio (%)N/A
Inventories (Millions)$545